Showing results (721-730 of 1,382) with videos related to
Sort By:
Pageof 139
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Basic Science and PathogenesisArturo J Barahona, Isha Mhatre-Winters, Ferass M Sammoura, et al.Optics Letters|December 18, 2009
Gas-phase single-shot thermometry at 1 kHz using fs-CARS spectroscopySukesh Roy, Waruna D Kulatilaka, Daniel R Richardson, et al.Mbio|June 23, 2016
Expanded Glucose Import Capability Affords Staphylococcus aureus Optimized Glycolytic Flux during InfectionNicholas P Vitko, Melinda R Grosser, Dal Khatri, et al.Health Promotion Practice|June 26, 2018
Characterizing Employees' Preferences for Incentives for Healthy Behaviors: Examples to Improve Interest in Wellness ProgramsKristi Rahrig Jenkins, Nour Fakhoury, Caroline R Richardson, et al.Cardiorenal Medicine|September 26, 2019
Elevated Serum Uric Acid and Self-Reported Heart Failure in US Adults: 2007-2016 National Health and Nutrition Examination SurveyMichelle L Stone, Michael R Richardson, Larry Guevara, et al.Biochimica Et Biophysica Acta|May 20, 2008
Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agentsD R Richardson, D S Kalinowski, S Lau, et al.Medical Education|January 23, 2019
Transphobia rather than education predicts provider knowledge of transgender health careDaphna Stroumsa, Deirdre A Shires, Caroline R Richardson, et al.Mutation Research|April 1, 1985
Chloracetamide-N-metholol: an example of an in vitro and in vivo clastogen which is non-mutagenic to SalmonellaJ Ashby, C R Richardson, P A Lefevre, et al.British Journal of Pharmacology|March 19, 2003
Identification of the di-pyridyl ketone isonicotinoyl hydrazone (PKIH) analogues as potent iron chelators and anti-tumour agentsErika M Becker, David B Lovejoy, Judith M Greer, et al.Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry|October 18, 2003
Cytotoxic iron chelators: characterization of the structure, solution chemistry and redox activity of ligands and iron complexes of the di-2-pyridyl ketone isonicotinoyl hydrazone (HPKIH) analoguesPaul V Bernhardt, Lorraine M Caldwell, Timothy B Chaston, et al.Pageof 139